The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection

Oncologist

Volumn 11, Issue 4, 2006, Pages 393-396

  De Melo Martín, Inmaculada ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cervical cancer; Ethics; HPV; Justice

Indexed keywords

WART VIRUS VACCINE;

ANTIGEN ANTIBODY REACTION; DISEASE ASSOCIATION; HEALTH CARE; HEALTH CARE SYSTEM; HUMAN; IMMUNIZATION; MEDICAL ETHICS; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; VACCINATION; VIRUS IMMUNITY; VIRUS INFECTION;

BIOETHICAL ISSUES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INFORMED CONSENT; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY PREVENTION; UTERINE CERVICAL NEOPLASMS; VIRAL VACCINES;

EID: 33645754956     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.11-4-393     Document Type: Review

References (38)

1. Maugh TH. Vaccine blocks most cancers of the cervix. Los Angeles Times. October 7, 2005.
2. Grady D. Vaccine prevents most cervical cancer. The New York Times, October 7, 2005. Available at http://www.nytimes.com.
3. Howard Price J. Vaccine blocks cancer cause. The Washington Times, October 7, 2005.
4. Hawkes N. New cancer vaccine will end routine smear tests. The Times, October 07, 2005. Available at http://www.timesonline.co.uk/article/0,,2- 1815129,00.html. Accessed January 20, 2006.
5. Mahdavi A, Monk BJ. Vaccines against human papillomavirus and cervical cancer: promises and challenges. The Oncologist 2005;10:528-538.
6. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999;26(4 suppl):S2-S7.
7. Bosch FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
8. Parkin DM, Bray F, Ferlay J et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
9. Denny L. The prevention of cervical cancer in developing countries. BJOG 2005;112:1204-1212.
10. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
11. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics 2005;23:1107-1122.
12. Kahn JA. Vaccination as a prevention strategy for human papillomavirus-related diseases. J Adolesc Health 2005;37(6 suppl):S10-S16.
13. Villa LL, Costa RL, Petta CA et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-278.
14. Harper DM, Franco EL, Wheeler C et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 2004;364:1757-1765.
15. Cohen J. Public health. High hopes and dilemmas for a cervical cancer vaccine. Science 2005;308:618-621.
16. Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 2005;16:63-70.
17. de Sanjose S, Bosch FX, Munoz N et al. Social differences in sexual behaviour and cervical cancer. IARC Sci Publ 1997;138:309-317.
18. American Cancer Society. Cancer Prevention and Early Detection Facts and Figures 2005. Atlanta: American Cancer Society, 2005:1-60.
19. Loerzel VW, Bushy A. Interventions that address cancer health disparities in women. Fam Community Health 2005;28:79-89.
20. Franco EL, Harper DM. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 2005;23:2388-2394.
21. Jacob M, Bradley J, Barone MA. Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs? Sex Transm Dis 2005;32:635-640.
22. Baleta A. African conference highlights gaps in vaccination. Lancet Infect Dis 2005;5:472-473.
23. The United Nations Children's Fund (UNICEF). The State of the World's Children 2004. New York: UNICEF, 2003:1-148.
24. Geipert N. Vaccinating men for HPV: new strategy for preventing cervical cancer in women? J Natl Cancer Inst 2005;97:630-631.
25. McPartland TS, Weaver BA, Lee SK et al. Men's perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer. J Am Coll Health 2005;53:225-230.
26. Holmes H, Hoskins B, Gross M, eds. Birth Control and Controlling Birth: Women-Centered Perspectives. Clifton, NJ: Humana Press, 1980:1-338.
27. Nelson HL, Nelson JL. Feminism, social policy, and long-acting contraception. Hastings Cent Rep 1995;25:S30-S32.
28. Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis 2005;191(suppl 1):S97-S106.
29. Goodenough P. Vaccine for Cancer-Causing Virus Could Spark Controversy. CNSNews.com. April 28, 2005. Available at http://www.cnsnews. com/ViewPrint.asp?Page=%5CForeignBureaus%5Carchive%5C20050 4%5CFOR20050428b. html. Accessed December 13, 2005.
30. Gujon J. Cancer and the culture wars. The coming storm over a cancer vaccine. Fortune, October 31, 2005.
31. Washam C. Targeting teens and adolescents for HPV vaccine could draw fire. J Natl Cancer Inst 2005;97:1030-1031.
32. Stein R. Cervical cancer vaccine gets injected with a social issue. Washington Post, October 31, 2005:A03.
33. Centers for Disease Control and Prevention (CDC). Youth Risk Behavior Surveillance - United States, 2003. Surveillance Summaries, May 21, 2004. MMWR 2004;53(No. SS-2).
34. Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 2005;37(6 suppl):S17-S23.
35. Zimet GD, Mays RM, Sturm LA et al. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 2005;159:132-137.
36. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 2004;58:1405-1413.
37. Liddon N, Pulley L, Cockerham WC et al. Parents'/guardians' willingness to vaccinate their children against genital herpes. J Adolesc Health 2005;37:187-193.
38. Davis K, Dickman ED, Ferris D et al. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004;8:188-194.